Clinical Trial Update: Efficacy and Safety of Berlim 25/10 Association in the Treatment of Type II Diabetes Mellitus and Dyslipidemia [Phase 3]

View source ↗

Summary

Clinical trial update for Berlim 25/10 in Type 2 Diabetes Mellitus and Dyslipidemia (Phase 3) with status currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyslipidemia
• Type 2 Diabetes Mellitus

Drugs mentioned

• Berlim 25/10

Snippet

Sponsor: EMS | Conditions: Type 2 Diabetes Mellitus, Dyslipidemia | Phase 3 | Status: UNKNOWN